Courses & tests for Genekor's new commers 

HerediGENE® New members

HerediGENE® is a diagnostic multi-gene test for hereditary cancer, which analyses 52 genes, including BRCA1 and BRCA2, which are involved in the increased risk of breast, ovarian, prostate, colorectal and other hereditary cancers. DX® New Employees

The ComPlit DX® multigene test provides important information on tumor biology and can lead to the identification of carcinogenic mutations known as 'Driver Mutations'. This information helps the doctor and the patient to reach the most effective personalised treatment.

Oncotype DX® New Employees

The only test in the world that predicts patient's response to chemotherapy in early breast cancer